Search All CIRM Grants
Information about disease focus, human stem cell use or new cell line generation will typically not be available on the website until a few months after the award is announced. Disease categories are provided for awards that might impact a given disease or related area, whether those awards are for translational research on new therapy candidates or for basic research to address a biological question that is relevant to that disease.
Learn more about stem cell research:
Stem Cell Basics Primer | Stem Cell Videos | What We Fund | Disease Information
| Institution | Researcher name | Grant Type | Grant Title | Committed Funds |
|---|---|---|---|---|
| Sanford-Burnham Medical Research Institute | Evan Snyder | Early Translational | 'Developmental Candidates' for Cell-Based Therapies for Parkinson's Disease (PD) | $3,562,824 |
| Sanford-Burnham Medical Research Institute | Mark Mercola | Disease Team Planning | 'Stem Cell Therapies for Heart Failure' | $53,150 |
| Scripps Research Institute | Peter Schultz | SEED | A Chemical Approach to Stem Cell Biology | $784,900 |
| University of California San Francisco | Jeffrey Lotz | Disease Team Planning | A CIRM Disease Team for the Repair of Traumatically Injured and Arthritic Cartilage | $55,000 |
| University of California San Francisco | Jeffrey Bluestone | Disease Team Planning | A CIRM Disease Team for the Treatment and Cure of Diabetes | $55,000 |
| University of Southern California | Roberta Brinton | Disease Team Planning II | A CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer's Disease | $107,989 |
| University of California Irvine | Leslie Thompson | Early Translational II | A hESc-based Development Candidate for Huntington's Disease | $3,799,817 |
| The Salk Institute for Biological Studies | Senyon Choe | SEED | A method to maintain and propagate pluripotent human ES cells | $796,348 |
| Stanford University | Judith Shizuru | Disease Team Planning II | A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants | $109,676 |
| University of California Irvine | Orhan Nalcioglu | Tools & Technology | A MULTI-MODALITY MOLECULAR IMAGING SYSTEM (MRSPECT) FOR IN VIVO STEM CELL TRACKING | $719,798 |
| OncoMed Pharmaceuticals Inc | Timothy Hoey | Disease Team Planning II | A New Cancer Therapeutic to Reduce CSC Frequency | $65,120 |
| University of California Irvine | Andrew Putnam | New Faculty I | A Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells | $2,108,683 |
| University of California San Diego | Shyni Varghese | New Faculty II | A Novel Microenvironment-Mediated Functional Skeletal Muscle from Human Embryonic Stem Cells and their In Vivo Engraftment | $2,300,569 |
| Gamma Medica-Ideas Inc. | Douglas Wagenaar | Tools & Technology | A Novel SPECT Microscopy System for 3D Imaging of Single Stem Cells In Vivo | $949,748 |
| University of California Riverside | Prudence Talbot | Shared Labs | A Stem Cell Core Facility for Studying Human Embryonic Stem Cell Differentiation | $3,658,353 |
| BioTime Inc. | Michael West | Early Translational | Addressing the Cell Purity and Identity Bottleneck Through Generation and Expansion of Clonal Human Embryonic Progenitor Cell Lines | $4,721,706 |
| University of California Davis | Martin Birchall | Disease Team Planning II | Airways for Children | $71,218 |
| University of California Davis | Mark Zern | Comprehensive | An in vitro and in vivo comparison among three different human hepatic stem cell populations. | $2,504,614 |
| Sanford-Burnham Medical Research Institute | Alexey Terskikh | SEED | Analysis of Candidate Neural Crest Cells Derived from Human ES Cells | $759,000 |
| Stanford University | Irving Weissman | Tools & Technology II | Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs | $1,869,487 |
| University of California Santa Cruz | Joel Kubby | Tools & Technology | AO Wide-Field Microscope | $552,985 |
| Palo Alto Institute for Research and Education | Husein Hadeiba | Transplantation Immunology | Application of Tolerogenic Dendritic Cells for Hematopoietic Stem Cell Transplantation | $885,475 |
| University of California Santa Cruz | David Feldheim | SEED | Assessing the role of Eph/ephrin signaling in hESC growth and differentiation | $499,999 |
| Cedars-Sinai Medical Center | Eduardo Marban | Disease Team | Autologous cardiac-derived cells for advanced ischemic cardiomyopathy | $5,560,232 |
| Scripps Research Institute | Martin Friedlander | Early Translational | Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration | $5,945,738 |
| Buck Institute for Age Research | Xianmin Zeng | Early Translational II | Banking transplant ready dopaminergic neurons using a scalable process | $6,016,624 |
| Stanford University | Karl Deisseroth | New Faculty I | Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny | $3,154,719 |
| University of California San Diego | Charles King | Basic Biology III | Biological relevance of microRNAs in hESC differentiation to endocrine pancreas | $1,313,649 |
| University of California Davis | Roslyn (Rivkah) Isseroff | Early Translational II | Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds | $4,526,900 |
| Pasadena City College | Pamela Eversole-Cire | Bridges | Bridges to Stem Cell Research at Pasadena City College | $3,609,138 |
| University of California Merced | Kara McCloskey | New Faculty II | Building Cardiac Tissue from Stem Cells and Natural Matrices | $1,706,255 |
| Sanford-Burnham Medical Research Institute | Mark Mercola | Training I | Burnham Institute CIRM Stem Cell Training Grant (Type II) | $1,489,640 |
| California State Polytechnic University Pomona | Jill Adler-Moore | Bridges | Cal Poly Pomona and Cal State LA Collaborative CIRM Bridges Program to Enhance Stem Cell Research Training and Education | $3,008,975 |
| California State University San Marcos | Bianca Mothe | Bridges | California State University-San Marcos CIRM Bridges to the Stem Cell Research Training Grant | $3,613,311 |
| Scripps Research Institute | Peter Schultz | Early Translational II | Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis | $6,792,660 |
| Cedars-Sinai Medical Center | Eduardo Marban | Disease Team Planning | Cedars-Sinai Heart Disease Regenerative Medicine Team Planning Award | $46,886 |
| ViaCyte Inc. | Emmanuel Baetge | Disease Team | Cell Therapy for Diabetes | $19,999,937 |
| University of California Los Angeles | Siavash Kurdistani | SEED | Cellular epigenetic diversity as a blueprint for defining the identity and functional potential of human embryonic stem cells | $641,047 |
| iPierian Inc. | Berta Strulovici | Basic Biology II | Cellular Reprogramming: Dissecting the Molecular Mechanism and Enhancing Efficiency | $1,458,000 |
| Stanford University | Marius Wernig | Tools & Technology II | Cellular tools to study brain diseases affecting synaptic transmission | $1,906,494 |
| University of California Los Angeles | Robb MacLellan | Basic Biology III | Characterization and Engineering of the Cardiac Stem Cell Niche | $1,181,306 |
| The Salk Institute for Biological Studies | Leanne Jones | New Faculty I | Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity | $2,675,234 |
| Sanford-Burnham Medical Research Institute | Mark Mercola | Comprehensive | Chemical Genetic Approach to Production of hESC-derived Cardiomyocytes | $3,036,002 |
| Children's Hospital of Los Angeles | David Warburton | Training II | CHLA Stem Cell Training Grant | $5,103,441 |
| Children's Hospital of Oakland Research Institute | Vasanthy Narayanaswami | Creativity Awards | CHORI/UC Berkeley Summer Stem Cell Research Internship Program for High School Students | $115,500 |
| Buck Institute for Age Research | Major Facilities | CIRM Center of Excellence at Buck Institute for Age Research | $20,500,000 | |
| Children's Hospital of Oakland Research Institute | Mark Walters | Disease Team Planning | CIRM Disease Team Planning Award | $55,000 |
| University of California Merced | Major Facilities | CIRM Major Facilities | $4,359,480 | |
| Sanford Consortium for Regenerative Medicine | Major Facilities | CIRM Major Facilities | $43,000,000 | |
| University of California Berkeley | Major Facilities | CIRM Major Facilities | $20,183,500 | |
| Page SUM | $201,991,127 | |||
| Total SUM | $1,328,177,425 |